BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• 

  Drug Development

  Navigating Deaths During Clinical Trials

  Fatalities are an unfortunate reality of clinical trials. How can companies best protect themselves?

  July 29, 2024

   · 

  6 min read

   · 

  Gail Dutton
• 

  Regulatory

  AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff

  Friday’s European Commission approval is a boost to AbbVie as the company looks to lean on its immunology assets, including Skyrizi, to soften the blow of Humira’s loss of exclusivity.

  July 29, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  BIOSECURE Act

  WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms

  With the BIOSECURE Act likely to be voted on in Congress this year, WuXi AppTec’s U.S. revenue dropped 1.2% in the first half of 2024 while the Chinese company increased its lobbying efforts.

  July 29, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Obesity

  FDA Flags Safety Risks of Compounded Versions of Novo’s Semaglutide, Reports Hospitalizations

  The regulator on Friday warned healthcare providers and patients about adverse events linked with dosing errors from compounded versions of Novo Nordisk’s weight-loss and diabetes drugs.

  July 29, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  FDA Action Alert: Adaptimmune, Zevra, Lykos and scPharma

  The FDA has four big events in the coming two weeks, including an advisory panel meeting for an ultra-rare disease.

  July 29, 2024

   · 

  5 min read

   · 

  Tristan Manalac
• 

  Regulatory

  Merck’s Keytruda in Combo With Padcev Granted CHMP Positive Opinion in Urothelial Carcinoma

  The combination therapy is one step closer to becoming a potential new first-line standard of care for patients with unresectable or metastatic urothelial carcinoma in Europe.

  July 29, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  Adaptimmune Gears Up for Potential Approval of First-in-Class Engineered T Cell Therapy

  After more than a decade devoid of therapeutic advancements, a first-in-class T cell receptor therapy could be on the immediate horizon for synovial sarcoma patients.

  July 29, 2024

   · 

  5 min read

   · 

  Kate Goodwin
• 

  Deals

  Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline

  Under the deal announced Monday with the California biotech, German pharma Boehringer Ingelheim is gaining access to novel immune checkpoint inhibitors designed to activate the immune system to fight cancer cells.

  July 29, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• Press Releases

  Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

  July 29, 2024

   · 

  7 min read
• Press Releases

  Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactivation of Lead Product Candidate, PALI-2108

  July 29, 2024

   · 

  5 min read